Chongqing Liyang Pharmaceutical Development Co., Ltd.
Company Profile
Chongqing Liyang Pharmaceutical Development Co., Ltd. was established in 2001 and is located in the Overseas Students Entrepreneurship Park on Kecheng Road, Jiulongpo District, Chongqing City. The company is recognized as a high-tech enterprise. For over two decades, its dedicated R&D team has consistently focused on pharmaceutical formulation development, undertaking more than one hundred research projects aimed at developing innovative improved drugs and generic formulations across various dosage forms. Notably, the company has accumulated extensive expertise in oral drug delivery systems. The company has achieved significant milestones, including obtaining China's first new drug certificate and drug registration approval for an orally disintegrating tablet. Additionally, it has secured an exclusive invention patent, along with a new drug certificate and registration approval, for its groundbreaking product—glutathione lozenges designed to deliver medication via an altered route and dosage form. Furthermore, the company has received support from two national funds dedicated to technological innovation within small and medium-sized science and technology enterprises. To date, the company’s innovative improved drugs and generic formulations—including those undergoing consistency evaluations—have resulted in five patented inventions for new drugs, five new drug certificates, and nearly one hundred drug registration approvals (including supplementary approvals) as well as clinical trial permits. All approved products have been successfully scaled up for industrial production, yielding substantial economic and social benefits for the company.
The company is equipped with state-of-the-art equipment, instruments, and data management systems necessary for small-scale trials and scale-up process development, as well as quality and stability studies across various pharmaceutical dosage forms. It has established specialized research platforms for oral solid dosage forms, liquid formulations (including injectables), and semi-solid preparations, enabling the provision of technical services for both chemical drug and traditional Chinese medicine registration studies, as well as for optimizing manufacturing processes.
The company's R&D team comprises experienced pharmaceutical professors, senior engineers, and professionals holding master's or bachelor's degrees, all with extensive expertise in formulation development and industrialization. The team has also benefited from the long-term technical support and guidance of several seasoned experts specializing in drug research and regulatory review. All research activities are conducted in strict compliance with relevant policies, regulations, and technical standards. Specific projects are systematically advanced according to established research plans, with continuous optimization and adjustments made as needed. Additionally, the team ensures ongoing enhancement of employees' R&D capabilities through self-study and targeted training programs. Robust implementation of a comprehensive management system effectively safeguards both project quality and timely progress.
The company upholds integrity and trustworthiness, adopts pragmatic management practices, delivers high-quality and efficient services, and enjoys an excellent reputation. It has established strong technical cooperation and collaborative relationships with numerous pharmaceutical enterprises, colleges, universities, and research institutions in Chongqing, Sichuan, Shandong, Jiangsu, and Shanghai.
We warmly look forward to collaborating with pharmaceutical companies, technology firms, universities, and research institutions—both domestic and international—to jointly contribute to the advancement of the pharmaceutical industry!
National Service Hotline
